Take care when prescribing new drug to treat impotence, MDs warned.
A new drug to treat impotence that has caused shock waves in the US because of incredible patient demand will likely be available in Canada by Christmas. Barbara Sibbald reports what physicians must know before prescribing it.
B
B
Sibbald
D002170:Canada; D017277:Drug Approval / Q000331:legislation & jurisprudence; D011307:Drug Prescriptions; D004791:Enzyme Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D018783:Impotence, Vasculogenic / Q000188:drug therapy*; D008297:Male; D010879:Piperazines / Q000009:adverse effects / Q000627:therapeutic use*; D011687:Purines; D000068677:Sildenafil Citrate; D013450:Sulfones
D004791:Enzyme Inhibitors; D010879:Piperazines; D011687:Purines; D013450:Sulfones; D000068677:Sildenafil Citrate